As per MRFR analysis, the Transradial Access Devices Market Size was estimated at 1.73 (USD Billion) in 2024. The Transradial Access Devices Market Industry is expected to grow from 1.85 (USD Billion) in 2025 to 3.46 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.20% during the forecast period (2025 - 2034). Increased health concerns and challenges have led to more expensive operations and more bariatric procedures are the key market drivers enhancing the market growth.Â
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology, declared the U.S. commercial release of the PreludeSYNC EZ Radial Compression Device on 21st November 2022. It is an additional product to the existing range of radial products that include Merit’s thin-walled hydrophilic sheath introducer, Prelude IDeal, offering better resistance against kink and compression. The PreludeSYNC EZ was created to optimize performance in clinical activities by attaining patent hemostasis (no bleeding) in the access site following radial artery procedures.
July 2022- Cordis announced the launch of RADIANCY clinical research in Europe. This prospective, multi-center, single-arm study aims to evaluate the safety and efficacy of the SMART RADIANZ Vascular Stent System intended for the treatment of lesions in iliac, superficial femoral or proximal popliteal arteries using radial artery access through 30 days follow-up.
Launch Minnesota in February 2022 gave nearly $440k in matching grants to 17 SBIR/STTR recipients, including Conway Medical, which developed a novel large-bore thrombectomy system suitable for transradial access.
In October 2021 Medtronic received CE mark approval for its radial artery access portfolio comprising Rist 079 Radial Access Guide Catheter plus Rist Radial Access Selective Catheter.
September 2021- Global medical technology leader Medtronic plc announced its CME variety clearance, including Rist 079 Radial Access Guide Catheter with Rist Radial Access Selective Catheter (CE Mark). The Rist 079 Radial Access Guide Catheter, is the first catheter specifically designed for entering neuro vasculature via the radial artery instead of the transfemoral approach.
The number of people with heart disease having heart attacks will rise, radial access techniques will be used more frequently in the field of cancer treatment, and technical advancements will all contribute to the transradial access market's expected growth in the coming years. The transradial access approach, which includes diagnostics angiography, angioplasty, and percutaneous stenting, is used to identify coronary artery disease. The transradial access kit has sheath introducers, guidewires, catheters, and other auxiliary items. The catheter sector is predicted to increase during the projection period. Transradial access through the left radial artery provides an alternative to traditional transfemoral access for catheter-based procedures, which are becoming more significant in all arterial vascular treatments.
Cardiac catheterization is an ordinary procedure that can be used to diagnose heart problems. By placing stents and using balloon angioplasty to clear blocked arteries, catheterization may also be utilized to treat heart disease in some instances. The transradial access method can find a blockage in a cardiac artery in a person with an illness and pain. A growing desire for interventional treatments utilizing radial artery access, an increase in the frequency of cardiovascular diseases brought on by lifestyle problems, and an increase in the usage of radial access devices in youngsters contribute to the growth of the transradial access devices market. Additionally, this process might help medical professionals decide on a treatment strategy. Pediatric patients' increasing usage of radial access devices is the main motivator for the transradial access devices industry trends.
The prevalence of cardiovascular disorders among children has increased due to changing lifestyles, unhealthful eating patterns, and other environmental variables, encouraging more pediatric patients to have cardiac catheterization. In the upcoming years, there is expected to be continued significant use of transradial access devices, particularly in anemia patients. The advantages of radial artery access encourage product adoption, including rapid and effective intravenous access, less vascular problems, lower risk of clot formation, less arterial blockage, and rapid hemostasis. Radial access in PCI has significantly decreased all-cause mortality, particularly post-PCI femoral hemorrhage and blood transfusion.
Market CAGR for transradial access devices is being driven by the growing technological developments in medical sector. Vascular access device technology will continue to progress, promoting market expansion. The process's success rate and results have improved thanks to a number of technological developments. In addition, the use of catheters and guidewires during transradial coronary artery procedures will increase because to advancements in cobalt chromium multi-link, triaxial, and interwoven wire technologies. Similar to flexibility, durability, delivery, and visibility, these attributes will create appealing market potential in the coming years.
Additionally, the prevalence of cardiovascular disorders increased due to unhealthful eating patterns, changing lifestyles, and other environmental variables, which is contributing more paediatric patients to have cardiac catheterization. In recent years, there has been a rise in the number of people experiencing atherosclerosis and other arterial problems. There are numerous products on the market that are used to treat these conditions. Obese people are more likely to get certain disorders. Moreover, Lack of exercise, Intake of processed foods, and living a sedentary lifestyle are factors in the rising patient population. Consuming alcohol and smoke also makes heart-related problems more likely, which is anticipated to drive the market growth in the coming years.
Increasing incidence of peripheral artery disease (PAD) anticipated to propel the market growth. According to the AHA, in August 2021, scientific study that was published in which more than 230 million people worldwide suffer from lower extremity peripheral artery disease (PAD), which has been linked to an increased risk of several adverse clinical outcomes, including cardiovascular diseases like coronary heart disease and stroke and limb outcomes like amputee status. The rise in the prevalence of PAD ultimately spurs demand for transradial access-required interventional procedures, fueling the market's expansion over the projection period.
For instance, according to WHO data released in June 2021, Nearly 33.5 million people worldwide experience atrial fibrillation (AFib), the most prevalent kind of severe arrhythmia. In addition, a report from the British Heart Foundation that was released in July 2021 stated that 7.6 million people in the UK suffer from heart and circulation disorders. Additionally, the 2022 AHA report estimates that roughly 244.1 million people worldwide have IHD. The highest prevalence rates of IHD were found in North Africa, the Middle East, Central and South Asia, and Eastern Europe in 2020. The number of patients with heart rhythm abnormalities is projected to climb as the world's ageing population grows. This will result in a greater uptake of transradial access, Thus, driving the Transradial Access Devices market revenue.
The  transradial access devices market segmentation, based on product includes catheters and guidewires. The catheters segment is anticipated to highest CAGR, accounting for 31.4% of market revenue. For catheter-based operations are increasingly important in all sorts of arterial vascular interventions, transradial access (TRA) via the left radial artery offers an alternative to conventional transfemoral access. In February 2022, According to a CDC update released 4.6% of individuals in the United States had coronary heart disease in 2020. Thus, over the course of the forecast period, the aforementioned reasons are anticipated to fuel segment growth for catheters.
The  transradial access devices market segmentation, based on application, includes drug administration and blood transfusion. The drug administration category accounted for the largest market share (75.9%). The increasing burden of chronic disorders anticipated to boost the segment growth. In addition, the rising use of vascular access devices in place of other technologies, particularly for the treatment of infectious diseases and some fatal diseases such as cancer.
The  transradial access devices market segmentation, based on disease area, includes cardiovascular disease, cancer, and strokes. The cardiovascular disease segment dominates the market during the forecast period. Risk factors, including a diet heavy in saturated fats, smoking, high blood pressure, and diabetes are the factors anticipated to drive the segment growth in the coming years.
The  transradial access devices market segmentation, based on end user, includes hospitals and clinics. Hospital segment accounted for major market share during the forecast period, due to an ageing population at risk for cardiovascular diseases and an increase in hospital admissions. The market will grow as a result of surgical procedures performed in hospital settings, such as transradial coronary catheterization treatments.
Figure 1: Â Transradial Access Devices Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
According to Merit Medical Systems, the PreludeSync EZ radial compression device was launched in the United States. According to Merit Medical, the PreludeSync EZ is a distinctive wristband with a cinch design. The corporation created it to allow for precise two-handed positioning and unobstructed vision of the access point. Optimizing bleeding control during radial artery surgeries is the aim. Consider catheter-based delivery techniques. For instance, a doctor will insert a catheter via a pinhole-sized incision in the wrist to do minimally invasive scans and operations near the heart. According to the manufacturer, the PreludeSync EZ offers a less complicated option than the two-strap compression band that is already available. A sizable window that offers good visibility is another element of the PreludeSync EZ's design that helps with exact positioning.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Transradial Access Devices market area will dominate this market, owing to CVDs are becoming more common, there are more conferences and workshops, studies, and clinical trials for vascular access devices. In February 2022, according to CDC updates, a fair or poor health status affects 2.1% of children in the United States in 2020, while 3.3% of children aged 5 to 11 missed 11 or more days of school in the previous 12 months as a result of an illness or accident. Growing healthcare costs and a well-established healthcare sector anticipated to propel the market growth. For instance, the United States spent USD 440,000 million on healthcare in 2020, according to NHEA statistics that was published in December 2021.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Â TRANSRADIAL ACCESS DEVICES MARKET SHARE BY REGION 2022 (USD Billion)Â Â Â Â Â Â
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Transradial Access Devices market accounts for the second-largest market share due to the rise in popularity of radial access devices among young patients. The rate of expansion of the transradial access market would be significantly impacted by the rise in the prevalence of cardiovascular diseases. The growing older population estimated to drive the market growth. Additionally, expanding medical tourism trends and rising per capita healthcare costs are propelling market expansion. Further, the German Transradial Access Devices market held the largest market share, and the UK Transradial Access Devices market was the fastest growing market in the European region
The Asia-Pacific Transradial Access Devices Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to obesity and heart diseases are more common. Additionally, the region is seeing an increase in the number of heart disease patients. Transradial access market growth will be impacted by changing lifestyles, growing healthcare expenses, and rising disposable incomes. Moreover, China’s Transradial Access Devices market held the largest market share, and the Indian Transradial Access Devices market was the fastest growing market in the Asia-Pacific region.
Transradial Access Devices Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Transradial Access Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Transradial Access Devices industry must offer cost-effective items.
The government and private businesses are making significant investments in R&D for technological advancements in the  Transradial Access Devices industry to benefit clients and increase the market sector. In recent years, the Transradial Access Devices industry has advantages such as, transradial access is safe method because it has many benefits over other procedures, including reduced costs and a lower rate of complications. Major players in the Transradial Access Devices market, including Becton, Dickinson & Company, Terumo Corporation, Teleflex Incorporated, Smiths Group Plc, Edward Lifescience Corporation, Medtronic Plc, and others, are attempting to increase market demand by investing in research and development operations.
Terumo, as a leader in medical technology has dedicated itself to "Contributing to Society through Healthcare" for the past 100 years. Terumo, a Tokyo-based company with  operations, employs more than 30,000 people to offer cutting-edge medical solutions in more than 160 nations and territories. The business began as a manufacturer of Japanese thermometers and has since supported healthcare. Now, its wide-ranging product portfolio includes medical items crucial for routine clinical practise, such as transfusion systems, diabetic care, and peritoneal dialysis treatments, in addition to vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology. Terumo continue to make an effort to benefit patients, doctors, and society at large. Terumo assist patients overcome physical and mental challenges while providing solutions that address a range of problems in healthcare settings. Company working with healthcare professionals to make a significant contribution to society.  In September 2021, partnership to provide enhanced monitoring insights for adult cardiac surgery patients is announced by Etiometry and Terumo Cardiovascular. Enhanced perioperative care for adult cardiac surgery patients will be made possible through a new alliance due to clinical decision support tools.
Teleflex is a leading  provider of medical solutions intended to enhance people's wellbeing and quality of life. The company is using "purpose driven innovation"—a continuous search for unmet clinical needs—to help patients and medical professionals. Solutions for vascular and interventional access, surgery, anaesthesia, cardiac care, urology, emergency medicine, and respiratory care are all included in our comprehensive offering. Worldwide, almost 14,000 Teleflex employees share the conviction that the work we perform each day has an impact. In February 2023, Teleflex adds two new FDA-approved catheter devices for use in complex percutaneous coronary interventions (PCI) to its portfolio of interventional cardiology products.
Key Companies in the Transradial Access Devices market include
Transradial Access Devices Industry Developments
September 2022:Terumo Releases Study Findings Highlighting Transradial to Peripheral (R2P) Interventions' Safety and Efficacy in Treating Complex Lower Extremity Peripheral Artery Disease (PAD). In a prospective post-market analysis, the transradial strategy enabled 92.3% same-day release with no major side events.
May 2023:Teleflex Incorporated announced two new devices that are intended to improve PICC insertion processes and lower the risk of problems. Vascular Access Specialists can implant PICCs more quickly and predictably by using new Arrow,® VPS Rhythm,® DLX Device with NaviCurveTM Stylet. Utilising the patient's cardiac electrical activity, the next-generation VPS Rhythm® DLX Device gives real-time catheter tip location information.
| Report Attribute/Metric | Details |
| Market Size 2024 | Â Â 1.73 (USD Billion) |
| Market Size 2025 | Â Â 1.85 (USD Billion) |
| Market Size 2034 | Â Â 3.46 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | Â Â 7.20 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Application, Disease Area, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Â Becton, Dickinson & Company, Terumo Corporation, Teleflex Incorporated, Smiths Group Plc, Edward Lifescience Corporation, Medtronic Plc, and others. |
| Key Market Opportunities | Obesity in children, healthier and more balanced diets |
| Key Market Dynamics | Increase in health difficulties and worries, leading in costly operations |
Frequently Asked Questions (FAQ) :
The Transradial Access Devices market size was valued at USD 1.5 Billion in 2022.
The market is projected to grow at a CAGR of 7.20% during the forecast period, 2025-2034.
North America had the largest share in the market
The key players in the market are Becton, Dickinson & Company, Terumo Corporation, Teleflex Incorporated, Smiths Group Plc, Edward Lifescience Corporation, Medtronic Plc.
The catheter category dominated the market in 2022.
The drug administration had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
